Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
Cancer
|
February 4, 2009
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy
Marc Peeters, Salvatore Siena, Eric Van Cutsem, et al.
Journal of Clinical Medicine
|
December 11, 2020
Changes in the Salivary Metabolic Profile of Generalized Periodontitis Patients after Non-surgical Periodontal Therapy: A Metabolomic Analysis Using Nuclear Magnetic Resonance Spectroscopy
Filippo Citterio, Federica Romano, Gaia Meoni, et al.
Frontiers in Oncology
|
February 6, 2025
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
Carmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Journal of the National Cancer Institute
|
June 29, 2007
Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials
Cornelis J A Punt, Marc Buyse, Claus-Henning Köhne, et al.
Journal of Clinical Epidemiology
|
October 16, 2004
Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties
Francesco Grossi, Ornella Belvedere, Gianpiero Fasola, et al.
Oncology Reports
|
December 19, 2001
Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas
Fabio Puglisi, Fabio Barbone, Gianluca Tell, et al.
Anticancer Research
|
August 28, 2004
Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancer
Fabio Puglisi, Mauro Mansutti, Giuseppe Aprile, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
July 22, 2005
The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies
Siegfried Segaert, Josep Tabernero, Olivier Chosidow, et al.
Clinical Colorectal Cancer
|
October 20, 2019
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses
Heinz-Josef Lenz, Guillem Argiles, Takayuki Yoshino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab
Andrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
Cancer
|
February 4, 2009
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy
Marc Peeters, Salvatore Siena, Eric Van Cutsem, et al.
Journal of Clinical Medicine
|
December 11, 2020
Changes in the Salivary Metabolic Profile of Generalized Periodontitis Patients after Non-surgical Periodontal Therapy: A Metabolomic Analysis Using Nuclear Magnetic Resonance Spectroscopy
Filippo Citterio, Federica Romano, Gaia Meoni, et al.
Frontiers in Oncology
|
February 6, 2025
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
Carmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Journal of the National Cancer Institute
|
June 29, 2007
Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials
Cornelis J A Punt, Marc Buyse, Claus-Henning Köhne, et al.
Journal of Clinical Epidemiology
|
October 16, 2004
Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties
Francesco Grossi, Ornella Belvedere, Gianpiero Fasola, et al.
Oncology Reports
|
December 19, 2001
Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas
Fabio Puglisi, Fabio Barbone, Gianluca Tell, et al.
Anticancer Research
|
August 28, 2004
Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancer
Fabio Puglisi, Mauro Mansutti, Giuseppe Aprile, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
July 22, 2005
The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies
Siegfried Segaert, Josep Tabernero, Olivier Chosidow, et al.
Clinical Colorectal Cancer
|
October 20, 2019
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses
Heinz-Josef Lenz, Guillem Argiles, Takayuki Yoshino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab
Andrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.
Page
of 8